Align Technology, Inc. - Consensus 'buy' rating and 5.0% Upside Potential
Align Technology, Inc. - Consensus 'buy' rating and 5.0% Upside Potential
Stay updated with breaking news from Invisalign First. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Align Technology, Inc. - Consensus 'buy' rating and 5.0% Upside Potential
Align Technology (Nasdaq:ALGN) announced today that the FDA granted 510(k) clearance for its Invisalign palatal expander system.
Align Technology Inc (NASDAQ: ALGN) shares are trading higher Thursday after Health Canada issued an updated medical device license for the company's
Invisalign® Palatal Expanders offer doctors a removeable, safe, and clinically effective alternative to traditional palatal expanders. Combined with Invisalign First™ aligners, Invisalign...
ALGN earnings call for the period ending September 30, 2023.